Drugs with this side effect as MedDRA Preferred Term
- 1,25(OH)2D3
- 2-hydroxysuccinaldehyde
- 4-methylpyrazole
- 5-ASA
- Pain: postmarketing, 11% - 23%
- Ache
- 5-FU
- 5-aminolevulinic acid
- 5-aza-2'-deoxycytidine
- 5-azacytidine
- A77 1726
- AMD3100
- Abarelix
- Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2
- BCNU
- Bivalirudin
- Brolene
- CAS 1405-87-4
- CGP 19835A
- Cancidas
- Carfilzomib
- DFMO
- EACA
- EDTA
- Enfuvirtide
- Eptifibatide
- FAMP
- FP-CIT
- Fe(III
- Pain: postmarketing, 0.7% - 10%
- Ache: postmarketing
- Forteo
- Gd-DTPA
- Ge-132
- Pain: postmarketing, 6% - 9%
- Ache: postmarketing
- Glat copolymer
- Goserelin
- Histrelin
- Humalog
- ICI 182,780
- Pain: postmarketing, 18.9% - 20.3%
- Implanon
- Pain: postmarketing, 1% - 5.6%
- Insulin
- K779
- Kaluril
- LMWH
- LY146032
- Lantus
- Leuprorelin
- Pain: postmarketing, 3% - 63%
- Stinging
- Lisinopril
- Lovaza
- Lutalyse
- Meropenem anhydrous
- Metrodin
- Pain: postmarketing, 0% - 8.11%
- Ache
- MnDPDP
- NovoLog
- Octreotide
- Pain: 0.5% - 8-10%
- Pain localised: very common
- Stinging
- Oestrogen
- Optison
- PGE1
- Pain: 1.03% - 1.5%
- Pain localised: 2% - 32%
- PGE2
- Photofrin
- Photofrin II
- Refludan
- Revasc
- SOM230
- SU5416
- Sativex
- SonoVue
- Stalevo 50
- Supremon
- T-A2-3
- Timentin
- Triptorelin
- UDCA
- VACV
- Vancocine
- Westcort
- abacavir
- acamprosate
- acebutolol
- acetate
- acitretin
- actinomycin D
- acyclovir
- adapalene
- Pain
- Stinging: 1% - 28.5%
- adenosine
- alcaftadine
- alendronate
- alfentanil
- alfuzosin
- allopurinol
- almotriptan
- alosetron
- Pain: infrequent, 5% - 7%
- amcinonide
- amiloride
- amiodarone
- amlexanox
- amlodipine
- amlodipine besylate
- ammonia
- ammonium lactate
- amphotericin B
- Pain: 12.8% - 14%
- Generalized aching
- amsacrine
- anagrelide
- anastrozole
- anthracycline
- apraclonidine
- aprepitant
- argatroban
- aripiprazole
- arsenic
- arsenic trioxide
- articaine
- atazanavir
- atenolol
- atomoxetine
- atorvastatin
- atovaquone
- atropine
- azelaic acid
- azelastine
- azithromycin
- aztreonam
- baclofen
- balsalazide
- beclomethasone
- beclomethasone dipropionate
- beclomethasone monopropionate
- bendamustine
- benzathine penicillin
- benzoyl
- benzydamine
- benzyl alcohol
- benzyl benzoate
- bepridil
- betamethasone dipropionate
- betaxolol
- bexarotene
- Pain: very common, 12% - 40%
- bezafibrate
- bicalutamide
- biguanide
- bimatoprost
- bisoprolol
- bleomycin hydrochloride
- boceprevir
- bortezomib
- bosentan
- bosutinib
- brimonidine
- Pain: 2.6% - 5.1%
- Stinging: common, very common, 7.1% - 35.5%
- brinzolamide
- bromcresol green
- bromfenac
- budesonide
- Pain: postmarketing, 2.27% - 11.7%
- Ache
- bupivacaine
- buprenorphine
- bupropion
- Pain: postmarketing, rare, infrequent, 1.3% - 3%
- buspirone
- busulfan
- butenafine
- cabazitaxel
- cabergoline
- calcipotriol
- candesartan cilexetil
- capecitabine
- capreomycin
- carbachol
- carbamazepine
- carbidopa
- carboplatin
- carboprost
- carnitine
- carvedilol
- cefaclor
- cefazolin
- cefditoren
- cefepime
- cefotaxime
- cefoxitin
- cefpodoxime
- Pain
- Generalized aching
- Pain localised
- cefprozil
- ceftaroline
- ceftazidime
- ceftizoxime
- ceftobiprole
- ceftriaxone
- cefuroxime
- cetirizine
- cevimeline
- chlorambucil
- chloramphenicol
- chlorhexidine
- ciclopirox
- cidofovir
- cilazapril
- cilostazol
- cinoxacin
- ciprofloxacin
- Pain: postmarketing, uncommon
- Stinging
- cisplatin
- citalopram
- Pain: infrequent, frequent, 1.3%
- cladribine
- clarithromycin
- Pain: uncommon
- Ache: uncommon
- clindamycin
- Pain
- Generalized aching
- Stinging
- clindamycin phosphate
- clobetasol
- Pain: postmarketing
- Stinging
- clobetasol propionate
- clofarabine
- clomiphene citrate
- clomipramine
- clonazepam
- clonidine
- clopidogrel
- clotrimazole
- clozapine
- colesevelam
- colestimide
- colestipol
- colestyramine
- conivaptan
- conjugated estrogens
- Pain: postmarketing, 0.714% - 1.4%
- copolymer 1
- copper
- cortisol
- cyanocobalamin
- cyclizine
- cyclophosphamide
- cyproterone
- cytarabine
- cytokinin
- dacarbazine
- dalteparin
- dantrolene
- darifenacin
- darunavir
- dasatinib
- deferiprone
- deferoxamine
- degarelix
- delavirdine
- deprenyl
- Pain: 8%
- Ache: 1%
- Generalized aching
- desmopressin
- Pain: 0% - 2%
- Pain burning
- desonide
- desoximetasone
- dexamethasone
- dexamethasone sodium phosphate
- dexmedetomidine
- dexrazoxane
- diatrizoate
- diazepam
- diazoxide
- diclofenac
- Pain: postmarketing, 0% - 30%
- Stinging
- dicloxacillin
- dicyclomine
- didanosine
- dihydroergotamine
- diltiazem
- dimercaprol
- dimercaptosuccinic acid
- dipivefrin
- dipyridamole
- disopyramide
- disulfiram
- docetaxel
- Pain: postmarketing, uncommon, 0% - 2%
- Pain localised: postmarketing, common
- dofetilide
- dolasetron
- donepezil
- dorzolamide
- doxazosin
- doxepin
- doxorubicin
- Pain: postmarketing, common, 1.2% - 7.4%
- Stinging
- doxycycline
- Pain: 1.5% - 23%
- Ache: 1.2% - 1.6%
- doxycycline hyclate
- duloxetine
- ecallantide
- echothiophate
- econazole
- efavirenz
- eletriptan
- eliglustat
- emedastine
- emtricitabine
- Pain: postmarketing, common
- entacapone
- ephedrine
- eplerenone
- eprosartan
- ergotamine
- eribulin
- erlotinib
- ertapenem
- erythromycin
- esmolol
- esomeprazole magnesium
- estazolam
- estradiol
- Pain: postmarketing, 0% - 12.5%
- Ache
- estradiol cypionate
- estradiol valerate
- estriol
- estrone
- ethacrynic acid
- etodolac
- etomidate
- etoposide
- etoposide phosphate
- etoricoxib
- etravirine
- everolimus
- Pain: very common, 3.27% - 15.4%
- exemestane
- ezetimibe
- famotidine
- febuxostat
- felbamate
- fenofibrate
- fenofibric acid
- fentanyl
- Pain: postmarketing
- Chronic pain: postmarketing
- Acute pain: postmarketing
- ferumoxytol
- fexofenadine
- finasteride
- flecainide
- florbetaben
- fluconazole
- fludarabine
- flumazenil
- flunisolide
- Pain: 1.8% - 4.6%
- Stinging
- fluocinolone acetonide
- fluocinonide
- fluorescein
- Pain: postmarketing, uncommon
- Ache
- fluorometholone
- fluoxetine
- fluphenazine decanoate
- flurbiprofen
- fluticasone
- Pain: postmarketing, 2% - 4%
- Ache
- Stinging: 0% - 5%
- fluticasone propionate
- Pain
- Ache
- Stinging: 0% - 1.28%
- fluvastatin
- fluvoxamine
- Pain: infrequent, 4.4% - 10%
- Ache
- fondaparinux
- formoterol
- fosaprepitant dimeglumine
- foscarnet
- fosfomycin
- fosfomycin trometamol
- fosinopril
- fosinoprilat
- fospropofol
- fotemustine
- frovatriptan
- furosemide
- fusidic acid
- gabapentin
- Pain: postmarketing, rare, 1.1% - 30%
- gadobenate dimeglumine
- gadobutrol
- gadodiamide
- gadofosveset
- gadolinium
- Pain: postmarketing, 0.4% - 1.83%
- gadopentetate
- gadoteridol
- gadoversetamide
- gamma-aminobutyric acid
- ganciclovir
- gefitinib
- gemcitabine
- gemfibrozil
- gemifloxacin
- gliclazide
- glipizide
- glucose
- glucose solution
- glutamine
- glycerol
- glycine
- glycopyrrolate
- gonadorelin
- granisetron
- halobetasol
- heparin
- hepatitis B vaccines
- histamine
- homatropine
- hydrochlorothiazide
- hydromorphone
- Pain: 2.34%
- Acute pain
- Ache
- Pain worsened
- hydroxocobalamin
- hydroxybutyrate
- hydroxychloroquine
- hydroxyurea
- ibandronate
- icodextrin
- ifosfamide
- iloprost
- imatinib
- imiquimod
- Pain: uncommon, 0% - 8%
- Stinging: 0.905% - 2.79%
- indapamide
- indinavir
- indomethacin
- insulin detemir
- iodide
- iodixanol
- iohexol
- iopamidol
- iopromide
- Pain: postmarketing, 0.1%
- iotrolan
- Pain
- Pain localised: 2.1%
- ioversol
- ioxaglate
- ioxilan
- ipratropium bromide
- Pain: postmarketing, 0.9% - 4.1%
- irbesartan
- irbesartan-hydrochlorothiazide
- irinotecan
- isomannide
- isopropyl unoprostone
- isosorbide-5-mononitrate
- itraconazole
- ivermectin
- ixabepilone
- kanamycin
- ketamine
- ketoconazole
- Pain: postmarketing
- Stinging
- ketorolac
- ketorolac tromethamine
- ketotifen
- labetalol
- lactate
- lamivudine
- lamotrigine
- Pain: frequent, 0% - 6.2%
- lanreotide
- lansoprazole
- lasofoxifene
- latanoprost
- leflunomide
- lenalidomide
- Pain: postmarketing, uncommon
- letrozole
- leuprorelin acetate
- Pain: 2.3% - 32.7%
- Stinging: 16% - 34.6%
- levetiracetam
- levobunolol
- levocabastine
- levodopa/carbidopa
- levonorgestrel
- lidocaine
- lincomycin
- lindane
- linezolid
- lithium carbonate
- lodoxamide
- lodoxamide tromethamine
- loratadine
- lorazepam
- losartan
- loteprednol etabonate
- lovastatin
- lubiprostone
- mTHPC
- mafenide acetate
- malvidin
- Pain: 2.6% - 5.1%
- Stinging: 7.1% - 35.5%
- mannitol
- maraviroc
- medrysone
- megestrol
- megestrol acetate
- melatonin
- meloxicam
- melphalan
- memantine
- meropenem
- mesna
- Pain: postmarketing, 7.6% - 10%
- metaproterenol
- methadone
- methocarbamol
- methotrexate
- methyl aminolevulinate
- Pain: postmarketing, 0% - 86.5%
- Stinging
- methylene blue
- methylnaltrexone
- methylphenidate
- Pain: postmarketing, 1.2% - 1.7%
- methysergide
- metolazone
- metoprolol
- metronidazole
- Pain
- Stinging: 10.3% - 15.2%
- metyrapone
- mexiletine
- miconazole
- midazolam
- midodrine
- mifepristone
- miglustat
- minocycline
- mipomersen
- mirtazapine
- misoprostol
- Pain: postmarketing
- Ache: postmarketing
- mitomycin C
- mitotane
- Pain
- Ache
- Generalized aching
- mitoxantrone
- modafinil
- moexiprilat
- mometasone
- mometasone furoate
- monoethanolamine
- montelukast
- morphine
- Ache
- Pain: postmarketing, 3%
- Pain worsened
- moxifloxacin
- moxonidine
- mupirocin
- Pain
- Stinging: uncommon, 2%
- mycophenolate mofetil
- mycophenolic acid
- nabilone
- nadolol
- nafcillin
- naftifine
- Pain: postmarketing
- Stinging: 5% - 6%
- naloxone
- naltrexone
- naproxen
- naratriptan
- Pain: infrequent, common, 2% - 4%
- Stinging: infrequent
- nedocromil sodium
- nefazodone
- nelarabine
- nelfinavir
- nevirapine
- niacin
- nicardipine
- nicorandil
- nicotine
- nifedipine
- nilotinib
- nilutamide
- nitazoxanide
- nizatidine
- nystatin
- ofatumumab
- ofloxacin
- ogen
- olanzapine
- olmesartan
- Pain: common, 0.568% - 1.54%
- olmesartan medoxomil
- olopatadine
- omeprazole
- ondansetron
- Pain: postmarketing, 2.19%
- orlistat
- oseltamivir
- oxaliplatin
- Pain: very common, 1% - 14%
- oxcarbazepine
- oxiconazole
- oxybutynin
- oxycodone
- Acute pain
- Ache
- Pain worsened
- oxymorphone
- paclitaxel
- Pain: common, very common
- paliperidone
- palonosetron
- pamidronate
- Pain: common, 0% - 15%
- Generalized aching: common
- pantoprazole
- paricalcitol
- paroxetine
- Pain: common, frequent, 3%
- pazopanib
- pemetrexed
- penbutolol
- penciclovir
- penicillin
- pentamidine
- pentostatin
- pergolide
- perindopril
- perindopril erbumine
- permethrin
- perphenazine
- phencyclidine
- phenobarbital
- phentolamine
- phenylephrine
- phenyllactate
- phosphate
- pilocarpine
- pimecrolimus
- pindolol
- piperacillin
- piroxicam
- podophyllotoxin
- Pain: 11.5% - 72%
- Stinging: 7%
- polymyxin B
- pomalidomide
- ponatinib
- posaconazole
- potassium
- potassium phosphate
- pralidoxime
- pramipexole
- pravastatin
- Pain
- Ache
- Pain localised: 1.4% - 10%
- prazosin
- prednicarbate
- prednisolone
- prednisolone acetate
- pregabalin
- prilocaine
- probenecid
- procarbazine
- progesterone
- promethazine
- propafenone
- proparacaine
- propofol
- propranolol
- prostacyclin
- quetiapine
- quinidine
- quinol
- rabeprazole
- radium
- raloxifene
- raltegravir
- raltitrexed
- ranitidine
- rapamycin
- rasburicase
- regadenoson
- Pain: postmarketing
- Generalized aching: uncommon
- regorafenib
- remifentanil
- Pain: 1.26% - 17.5%
- Ache: uncommon, 0% - 2.64%
- rescinnamine
- reserpine
- retapamulin
- retinoic acid
- Pain: postmarketing, very common, 0% - 37%
- Generalized aching
- Stinging: common
- ribavirin
- rifabutin
- rifampicin
- rifapentine
- rifaximin
- riluzole
- risedronate
- risperidone
- ritonavir
- rivaroxaban
- rivastigmine
- Pain: infrequent, frequent
- Stinging
- rizatriptan
- ropinirole
- Pain: infrequent, 5% - 8%
- ropivacaine
- rosuvastatin
- rotigotine
- salbutamol
- salicylate
- salmeterol
- salmon calcitonin acetate
- samarium
- saquinavir
- scopolamine
- sertraline
- sevelamer
- sevelamer hydrochloride
- sevoflurane
- sibutramine
- sildenafil
- simvastatin
- sitagliptin
- sitaxsentan
- sodium cromoglycate
- sodium ferric gluconate
- sodium iothalamate
- sodium tetradecyl sulphate
- sofosbuvir
- sorafenib
- Pain: postmarketing, very common, 0% - 31%
- sotalol
- Pain: 2.5% - 4.1%
- Ache
- Pain localised: 1% - 3%
- sparfloxacin
- stavudine
- streptozotocin
- strontium ranelate
- sugammadex
- sulconazole
- sulfacetamide
- sumatriptan
- Pain: postmarketing, infrequent, common, 1% - 8%
- Stinging: postmarketing, infrequent
- sunitinib
- suprofen
- tacrolimus
- tadalafil
- tamoxifen
- tamsulosin
- tazarotene
- technetium-99m
- tegaserod
- telavancin
- telmisartan
- Pain: postmarketing, rare, 3.5%
- temozolomide
- Pain: uncommon, common, 1% - 3%
- temsirolimus
- tenofovir
- tenofovir disoproxil fumarate
- terazosin
- terbinafine
- terconazole
- tesamorelin
- testolactone
- testosterone
- testosterone propionate
- testosterone undecanoate
- tetracaine
- tetrahydrozoline
- tetrofosmin
- thalidomide
- thiotepa
- thymidine
- tiagabine
- ticlopidine
- tigecycline
- tiludronate
- timolol
- Pain
- Ache: postmarketing
- Stinging: 11.6% - 23.6%
- tipranavir
- tirofiban
- tobramycin
- Pain: very common, 8.1%
- Stinging
- tolcapone
- tolterodine
- topiramate
- topotecan
- torasemide
- toremifene
- tramadol
- Pain: postmarketing, uncommon
- Pain worsened: 2.8%
- tranylcypromine
- travoprost
- trazodone
- Pain: 5.1% - 5.6%
- Ache: 5.1% - 5.6%
- treprostinil
- triamcinolone
- triamcinolone acetonide
- triazolam
- trifluorothymidine
- tropicamide
- trovafloxacin
- unoprostone
- ustekinumab
- v 1784
- Pain: postmarketing, 3.2% - 15.6%
- Stinging
- valdecoxib
- valganciclovir
- valproate
- vandetanib
- vardenafil
- varenicline
- venlafaxine
- verapamil
- verteporfin
- vigabatrin
- vinblastine
- vincristine
- vinflunine
- vinorelbine
- Pain
- Acute pain
- Pain burning
- Ache
- vismodegib
- vitamin D2
- vitamin K
- voriconazole
- warfarin
- zafirlukast
- zalcitabine
- zaleplon
- zanamivir
- ziconotide
- zidovudine
- Pain: uncommon
- Generalized aching: postmarketing
- zidovudine/lamivudine
- zileuton
- zoledronic acid
- Pain: uncommon, common, very common, 1.5% - 24.2%
- zolmitriptan
- zolpidem
- zopiclone
- Pain: infrequent, 4% - 5%
- zuclopenthixol
|
Drugs with this indication
|